About Medreich
Medreich is a Healthcare company based in Bengaluru (India) founded in 1984, and was acquired by Meiji Seika Pharma in June 2014. Pharmaceutical contract manufacturing and development services are provided. Medreich has raised $25 million across 1 funding round from investors including Temasek and Meiji Seika Pharma. The company has 1,833 employees. Its chief executive, as recorded, is Pankaj Garg. Its Indian entity Medreich Limited reported revenue of ₹1,604 Cr. Medreich offers products and services including Formulation Development and Analytical Services. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.
Company details
Founded in 1984 in Bengaluru, India, Medreich operates in the pharmaceutical sector with contract manufacturing and development services. Formulation development, analytical testing, clinical and commercial production, and packaging are handled across dosage forms and therapeutic areas. Assistance is extended from proof-of-concept stages to final products, including patent-non-infringing formulations and niche generics for international markets. Pharmacovigilance is incorporated into operations.
- Headquarters Bengaluru, India
- Employees 1,833
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Phone•••• ••••
- Website medreich.com
- Social LinkedIn
- Acquired by Meiji Seika Pharma (Jun 2014)
- Legal Name Medreich Limited
- Date of Incorporation 16 Aug, 1973
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1,604 Cr
FY 2024 · +8% YoY
- Net Profit₹227 Cr
FY 2024 · 13% margin
- EBITDA₹295 Cr
FY 2024 · 17% margin
- Total Equity Funding$25M (USD)
in 1 rounds
- Latest Funding Round$25M (USD), Private Equity Round
Jun 2005
- InvestorsTemasek
& 1 more
- Employee Count1,833
- Acquired byMeiji Seika Pharma
(Jun 2014)
Associated legal entities of Medreich
Medreich operates through Medreich Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Medreich Limited CIN U24232KA1973PLC002383 | Active | 16 Aug 1973 | Bangalore, Karnataka | ₹1,604 Cr | 1,833 | 8 | View details |
Products & Services of Medreich
Medreich offers a comprehensive portfolio of products and services, including Formulation Development and Analytical Services.
Formulation development is conducted for patent non-infringing and niche generics in differentiated dosage forms.
Analytical services are performed with a diverse background in analytical methods for pharmaceutical applications.
Funding Insights of Medreich
Medreich has successfully raised a total of $25M through 1 strategic funding round. The most recent funding activity was a Private Equity Round of $25 million completed in June 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $25M
- Total Rounds 1
- Last Round Private Equity Round — $25M
- First Round $25M
(Jun 2005)
- Investors Count 1
All 1 funding rounds of Medreich with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2005 | $25M | Private Equity Round | – | Temasek | – |
2 investors in total: 2 institutional.
Investors in Medreich
Medreich has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Temasek and Meiji Seika Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
Specializes in developing, manufacturing, and marketing human vaccines, antibiotics, and prescription drugs. | 1916 | meiji-seika-pharma.co.jp | Chuo, Japan |
Investor details for Medreich
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Medreich Limited (Medreich)
Medreich Limited is the primary company behind Medreich. The board of Medreich Limited currently have 6 directors; the longest-serving is Pankaj Garg, appointed in 2015. 43 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Pankaj Garg DIN 03105139 | Managing Director | 31 Jul 2015 | 11 yrs 3 mo | Medreich Limited |
| Kenshi Murase DIN 08166228 | Director | 02 Jul 2018 | 8 yrs 4 mo | Medreich Limited |
| Ryoji Kikuchi DIN 09238868 | Director | 16 Jul 2021 | 5 yrs 3 mo | Medreich Limited |
| Misa Hirose DIN 09653163 | Director | 28 Jun 2022 | 4 yrs 4 mo | Medreich Limited |
| Tsutomu Yamada DIN 10237661 | Director | 31 Jul 2023 | 3 yrs 3 mo | Medreich Limited |
| Yasuhiro Nakagiri DIN 07796678 | Additional Director | 09 May 2024 | 2 yrs 5 mo | Medreich Limited |
People of Medreich
32 people are tracked at Medreich (12 in leadership, 20 in team); the tracked headcount is 1,833.
| Name | Role | Group |
|---|---|---|
| CEO & MD | Leadership | |
Ashish Bhati | AGM & Site QA Head | Leadership |
Dr. Lalit Aggarwal | Executive Vice President - Operations | Leadership |
Aravinda Karanth P | Deputy General Manager Human Resources | Leadership |
Renny Samuel | Vice President Human Resources | Leadership |
Nagaraj S | Associate Vice President | Leadership |
T.n. Sethu Raman | Head Of Procurement | Leadership |
J. B. Hari Prasad | General Manager Operational Excellence | Leadership |
Satish Sangam | Vice President - Corporate Quality Control | Leadership |
Subramaniam Ganapathy | Senior VP Marketing Services | Leadership |
Sreeni Reddy | Chief Financial Officer | Leadership |
Sat Rayat | General Manager - UK South Region | Leadership |
Mahendran S | Senior Executive | Team |
Karthikeyan Sundaram | Deputy Manager | Team |
Sanjay Sreenivas | Quality Assurance Officer | Team |
Harsha Somayaji | Manager | Team |
Mahesh Pudipati | Dy. Manager In Quality Assurance | Team |
Naga Kranthi Kumar Chintalapudi | Assistant Manager- Development Quality Assurance Department. | Team |
Harsha Kashyap Chirivirala | Senior Manager | Team |
Ravi Krishna | Assistant Manager | Team |
12 more people are available in the full profile.
Complete people profiles for Medreich
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Medreich
Figures of Medreich Limited, the primary company behind Medreich, for FY 2024. Revenue was ₹1,604 Cr (+8% year on year). Net profit was ₹227 Cr (13% margin). EBITDA was ₹295 Cr (17% margin). Revenue has grown at a compounded annual rate of +9% over three years and +9% over five years.
- ₹1,604 CrRevenue · FY 2024 · +8% YoY
- ₹227 CrNet profit · 13% margin
- ₹295 CrEBITDA · 17% margin
- ₹40.16 CrPaid-up capital
- 1,833Employees (provident fund records)
- +9%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Medreich Limited are on its company page.
Detailed financial statements for Medreich
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Medreich
3 dated milestones of Medreich across 30 years, from founding to its latest funding, stage changes and deals.
- Founded Medreich is founded.
- Funding First funding round of $25.0M.
- Exit Acquired by Meiji Seika Pharma.
Web traffic of Medreich
The website of Medreich (medreich.com) receives about 1.9K visits a month and ranks #7,047,446 among all websites worldwide, #6,878 in Biotechnology and Pharmaceuticals.
- Monthly visits1.9K
▼ 17.2% vs previous month
- Global rank#7,047,446
among all websites
- Category rank#6,878
Health · Biotechnology and Pharmaceuticals
- Bounce rate39%
- Pages per visit2.0
- Average visit33 sec
- DevicesDesktop 56% · Mobile 44%
Websites whose visitors overlap most with Medreich. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| balpharma.com | 100% | 3K | #7,146,280 | View details | |
kaplindia.com | kaplindia.com | 97% | #6,271,095 | – | |
| globalcalcium.com | 92% | #2,271,380 | View details | ||
| strides.com | 90% | 15.7K | #1,592,167 | View details | |
| microlabsltd.com | 90% | #1,920,866 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Medreich
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as Medreich (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | USD 508.93 M | 4,050 | ||
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | USD 6.44 B | 19,801 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Medreich
Medreich was founded in 1984 and raised its 1st funding round 21 years after it was founded.
Medreich is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Pankaj Garg is the CEO of Medreich, as recorded in our data.
Medreich is a funded company, having raised a total of $25M across 1 funding round to date. The company's 1st funding round was a Private Equity Round of $25M, raised on Jun 2005.
Medreich has 1,833 employees.
The primary company behind Medreich, Medreich Limited, reported revenue of ₹1,604 Cr for FY 2024, up 8% year on year.
Founded in 1984 in Bengaluru, India, Medreich operates in the pharmaceutical sector with contract manufacturing and development services. Formulation development, analytical testing, clinical and commercial production, and packaging are handled across dosage forms and therapeutic areas. Assistance is extended from proof-of-concept stages to final products, including patent-non-infringing formulations and niche generics for international markets. Pharmacovigilance is incorporated into operations.
Medreich offers Formulation Development and Analytical Services.
Medreich has 2 investors. Key investors include Temasek, and Meiji Seika Pharma.
Medreich operates through Medreich Limited.
Yes. Medreich was acquired by Meiji Seika Pharma in June 2014.
The legal entities of Medreich currently have 8 directors, including Ramapuram Sreenivasulu Reddy, Tsutomu Yamada, Pankaj Garg and others.